Display options
Share it on

CNS Neurosci Ther. 2012 Oct;18(10):855-63. doi: 10.1111/j.1755-5949.2012.00366.x. Epub 2012 Aug 23.

Ischemic postconditioning diminishes matrix metalloproteinase 9 expression and attenuates loss of the extracellular matrix proteins in rats following middle cerebral artery occlusion and reperfusion.

CNS neuroscience & therapeutics

Xiang-Rong Liu, Mei Luo, Feng Yan, Chen-Cheng Zhang, Si-Jie Li, Hai-Ping Zhao, Xun-Ming Ji, Yu-Min Luo

Affiliations

  1. Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Key Laboratory of Neurodegenerative Diseases (Capital Medical University), Ministry of Education, Beijing, China.

PMID: 22925005 PMCID: PMC6493466 DOI: 10.1111/j.1755-5949.2012.00366.x

Abstract

AIMS: Ischemic postconditioning (IPostC) has been proved to have neuroprotective effects for cerebral ischemia, but the underlying mechanism remains elusive. This study aimed at validating the neuroprotective effects of IPostC and investigating whether the neuroprotection of IPostC is associated with matrix metalloproteinase 9 (MMP9) and the extracellular matrix proteins, laminin and fibronectin, following cerebral ischemia/reperfusion in rats.

METHODS: The rats in middle cerebral artery occlusion (MCAO) group underwent MCAO and reperfusion, and the animals in MCAO + IPostC group were treated by occluding bilateral common carotid arteries for 10 seconds and then reperfusing for 10 seconds for five episodes at the beginning of MCAO. Apoptosis was detected with terminal deoxynucleotidyl transferase dUTP nick end labeling staining. The expression of MMP9, laminin, and fibronectin was measured with immunofluorescence and enzyme-linked immunosorbent assay.

RESULTS: IPostC reduced brain edema and infarct volume and improved the neurological function. Furthermore, IPostC decreased cell apoptosis compared with the MCAO group. Compared to the MCAO group, IPostC treatment reduced MMP9 expression. Moreover, the results showed that the expression of laminin and fibronectin significantly increased in the MCAO + IPostC group compared to the MCAO group.

CONCLUSION: These findings indicated that diminishment of MMP9 expression and the attenuation of degradation of laminin and fibronectin may be involved in the protective mechanisms of postconditioning against cerebral ischemia/reperfusion injury.

© 2012 Blackwell Publishing Ltd.

References

  1. Circulation. 2005 Oct 4;112(14):2143-8 - PubMed
  2. Stroke. 1993 Jan;24(1):117-21 - PubMed
  3. Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H579-88 - PubMed
  4. J Cereb Blood Flow Metab. 2006 Sep;26(9):1114-21 - PubMed
  5. Circ Res. 1989 Mar;64(3):437-48 - PubMed
  6. J Cereb Blood Flow Metab. 1997 Jun;17(6):605-11 - PubMed
  7. Brain Res. 2011 Jan 7;1367:85-93 - PubMed
  8. J Cereb Blood Flow Metab. 2008 Feb;28(2):232-41 - PubMed
  9. J Neurosurg. 1996 Jul;85(1):125-30 - PubMed
  10. Mol Cell Biochem. 2007 Feb;296(1-2):45-51 - PubMed
  11. Stroke. 2003 Sep;34(9):2165-70 - PubMed
  12. Eur J Pharmacol. 2001 Sep 21;427(3):263-76 - PubMed
  13. Circulation. 2005 Oct 4;112(14):2085-8 - PubMed
  14. Brain Res. 2012 Mar 22;1445:92-102 - PubMed
  15. J Neurochem. 2008 May;105(3):943-55 - PubMed
  16. Brain Res. 2011 Feb 23;1375:137-46 - PubMed
  17. J Neurotrauma. 2002 Nov;19(11):1411-9 - PubMed
  18. Nat Med. 2001 Mar;7(3):324-30 - PubMed
  19. Brain Res. 2009 Sep 8;1288:88-94 - PubMed
  20. Brain Res. 2006 Jul 7;1098(1):161-9 - PubMed
  21. Circulation. 1986 Nov;74(5):1124-36 - PubMed
  22. Ann Surg. 2006 Jul;244(1):148-53 - PubMed
  23. Pharmacology. 1996 Feb;52(2):113-8 - PubMed
  24. Stroke. 1986 May-Jun;17(3):472-6 - PubMed
  25. Biochem Biophys Res Commun. 2007 Aug 3;359(3):628-34 - PubMed
  26. J Lab Clin Med. 1996 Sep;128(3):251-8 - PubMed
  27. Am J Physiol. 1992 Oct;263(4 Pt 2):H1107-12 - PubMed
  28. Neurochem Int. 2011 Nov;59(6):749-58 - PubMed
  29. Stroke. 1989 Oct;20(10):1383-90 - PubMed
  30. Stroke. 2008 Aug;39(8):2362-9 - PubMed
  31. Am J Physiol Renal Physiol. 2000 Mar;278(3):F380-7 - PubMed
  32. J Cereb Blood Flow Metab. 1998 Nov;18(11):1163-72 - PubMed
  33. Neurosurg Focus. 2007 May 15;22(5):E4 - PubMed
  34. J Cereb Blood Flow Metab. 1996 Jul;16(4):566-77 - PubMed
  35. Stroke. 2008 Mar;39(3):983-90 - PubMed
  36. Stroke. 2003 Aug;34(8):2025-30 - PubMed
  37. J Neurochem. 2006 Jan;96(1):148-59 - PubMed
  38. Med Oncol. 2011 Jun;28(2):608-14 - PubMed
  39. Catheter Cardiovasc Interv. 2005 Jul;65(3):361-7 - PubMed
  40. Stroke. 2001 Dec 1;32(12):2762-7 - PubMed
  41. Stroke. 2010 Mar;41(3):e123-8 - PubMed
  42. J Neuroinflammation. 2009 Apr 15;6:13 - PubMed

Substances

MeSH terms

Publication Types